Trevi Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRVI and other ETFs, options, and stocks.

About TRVI

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson’s disease. 

CEO
Jennifer L. Good
CEOJennifer L. Good
Employees
25
Employees25
Headquarters
New Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded
2011
Founded2011
Employees
25
Employees25

TRVI Key Statistics

Market cap
208.95M
Market cap208.95M
Price-Earnings ratio
-10.29
Price-Earnings ratio-10.29
Dividend yield
—
Dividend yield—
Average volume
138.30K
Average volume138.30K
High today
$3.12
High today$3.12
Low today
$2.98
Low today$2.98
Open price
$3.02
Open price$3.02
Volume
25.27K
Volume25.27K
52 Week high
$4.00
52 Week high$4.00
52 Week low
$0.97
52 Week low$0.97
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.